• Skip to header navigation
  • Skip to members navigation
  • Skip to footer navigation
  • Skip to content
  • Members
  • Login
  • MDDA on social media: Twitter Facebook YouTube RSS Feed
Metabolic Dietary Disorders Association (MDDA) Metabolic Dietary Disorders Association (MDDA) - Ensuring all IEM's have informed choices and a better quality of life.
Metabolic Dietary Disorders Association (MDDA)

Ensuring all IEM's have informed choices and a better quality of life.

  • Home
  • Food
    • LowPro Inspo
    • Food Statistics
    • Recipes
    • Submit Recipe
    • Special Medical Foods
  • Diagnosis
    • 3-Methylcrotonyl CoA Carboxylase Deficiency (3MCC)
    • Arginase Deficiency (ARG)
    • Argininosuccinic Acidemia (ASA)
    • Citrullinaemia
    • Glutaric Acidaemia Type 1 (GA1)
    • Homocystinuria (HCU)
    • Isovaleric Aciduria (IVA)
    • Maple Syrup Urine Disease (MSUD)
    • Methylmalonic Aciduria (MMA)
    • Ornithine Transcarbamylase Deficiency (OTC)
    • Phenylketonuria (PKU)
    • Propionic Acidaemia (PA)
    • Tyrosinaemia Type 1 & 2 (TYRO)
  • Resources
    • Patient Pathways Telehealth Nurse
    • COVID-19
    • Trials and Research
    • Treatment Advancements
    • Metabolic Clinics
    • IEM Food Grant
    • School Starters
    • Government Carer Allowances
    • Handbooks / Guidelines
    • Care and Education
    • Literature and Presentations
    • Transitional Handbook
    • Videos
    • External Links
  • How to Help
    • Donate
    • Corporate Partnership
    • Become a Member
    • Fundraise
    • Join #teamMDDA
    • Volunteer
    • MDDA Program and Research Initiatives
    • Pathways
    • My LowPro Pal App
    • Zest
    • LowPro Eats
  • News & Events
    • News
    • MDDA Events
    • Newsletter Archives – members only
  • About MDDA
    • About MDDA
    • Our People
    • Our Partners
    • Strategic Priorities
    • Annual Reports
    • Website Terms of Use, Privacy & Social Media Policies
  • Marketplace
  • Members
    • Join/Renew
    • Terms & Conditions
    • Login To Renew
  • Contact
  • Show Search
Hide Search

PBAC Kuvan Deferral for maternal women with PKU

Dec 18, 2020

PBAC Kuvan Deferral for maternal women with PKU

The Metabolic Dietary Disorders Association recognises the decision by the Pharmaceutical Benefits Advisory Committee (PBAC) to defer the listing of Kuvan (sapropterin hydrochloride) on the Pharmaceutical Benefits Scheme (PBS) for maternal women living with phenylketonuria (PKU). We understand that the PKU community may feel disappointed by this decision, however, the deferral means the PBAC recognises the benefit of Kuvan for maternal PKU patients and remains open to listing the treatment on the PBS.

The deferral also ensures the PBAC can now work with the sponsor company (BioMarin) to seek further evidence and determine the best pathway forward to make Kuvan available for maternal PKU women.

MDDA, with the support of our PKU community, has been actively campaigning for a number of years to secure access to this treatment for all Australians with PKU who are responsive to Kuvan. Although the outcome has not been a straightforward recommendation, MDDA remain hopeful to secure subsidised access to Kuvan through the PBS for PKU women who are planning a pregnancy. We intend to continue to campaign for access to all safe and approved treatments for all Australians living with PKU. MDDA plan to investigate next steps of access to a generic option and other therapies currently available overseas.

We want to thank everyone who submitted a consumer comment to the PBAC about how important it is for PKU maternal women and our wider PKU community to get access to this treatment on the PBS.

Information regarding the PBAC outcome and brief summary can be found https://bit.ly/2Wt1oPe. MDDA will provide updates as they become available.

Any questions can be emailed to [email protected].

FacebookTweetPin
« MDDA Office & Supplier Christmas Trading Hours
Kuvan recommended by PBAC for treatment for maternal women living with PKU in Australia »

Reader Interactions

News

  • ANNOUNCEMENT: MDDA Family Retreat QLD July 2021 – POSTPONED

  • Fundraiser – Quilpie BBQ Breakfast for PKU

  • Rare Disease Day 2021

  • Dr Jim McGill receives 2021 Australia Day Honours

  • Kuvan recommended by PBAC for treatment for maternal women living with PKU in Australia

  • MDDA Office & Supplier Christmas Trading Hours

  • 2021 MDDA Family Retreat Postponement Details

  • MDDA @Home Retreat Video Snapshot

View All
  • Privacy Policy
  • Website Terms of Use

Copyright © 2017–2021 Metabolic Dietary Disorders Association · Website by Spinning Webs Media